Furthermore, studies on tumor samples from CRPC patients have revealed several mechanisms used by tumor cells to reactivate AR signaling, e.g. AR amplification or mutation, changes in the expression of enzymes involved in steroidogenesis, and intracrine androgen production [11]–[25]. Here, AR is linked to neoplasm.